The average expression levels of these genes across the two stages are analyzed and we find that CYP1B1 and MMP9 show an increasing trend in their average expression values from non-metastasis to metastasis stage.
← all excerpts
Disease biomarker identification from gene network modules for metastasized breast cancer.
2
—
—
The sentences
The other three genes XBP1, SCGB1D2 and MET show a decreasing trend during the progression phase.